Allspring Global Investments’s ADMA Biologics ADMA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.37M	Sell	479,579 -10,565	-2%	-$167K	0.01%	892
2025 Q4	$8.76M	Sell	490,144 -1,057,995	-68%	-$17.8M	0.01%	740
2025 Q3	$23.3M	Sell	1,548,139 -1,772,112	-53%	-$30.4M	0.04%	502
2025 Q2	$59.4M	Buy	3,320,251 +271,305	+9%	+$5.53M	0.1%	244
2025 Q1	$59.2M	Buy	3,048,946 +207,097	+7%	+$3.58M	0.1%	250
2024 Q4	$51M	Buy	2,841,849 +2,613,482	+1,144%	+$49.2M	0.08%	293
2024 Q3	$4.57M	Buy	228,367 +17,573	+8%	+$273K	0.01%	967
2024 Q2	$2.36M	Sell	210,794 -41,808	-17%	-$351K	﹤0.01%	1131
2024 Q1	$1.67M	Buy	252,602 +7,463	+3%	+$40.8K	﹤0.01%	1241
2023 Q4	$1.11M	Sell	245,139 -34,332	-12%	-$127K	﹤0.01%	1317
2023 Q3	$1M	Buy	279,471 +81,995	+42%	+$316K	﹤0.01%	1359
2023 Q2	$729K	Buy	197,476 +79,320	+67%	+$294K	﹤0.01%	1486
2023 Q1	$391K	Buy	118,156 +83,660	+243%	+$289K	﹤0.01%	1642
2022 Q4	$134K	Sell	34,496 -669	-2%	-$2.06K	﹤0.01%	1958
2022 Q3	$85K	Buy	+35,165	New	+$84.4K	﹤0.01%	2142